Abstract
The biodistribution of several radiolabeled somatostatin (SRIF) analogs was determined in the rat. Newly developed analogs BIM-23190 and BIM-23197 attained higher plasma levels and much greater target tissue concentrations than the clinically used BIM-23014 analog. Highest tissue concentrations of BIM-23190 and BIM-23197 were found in adrenal, kidney, pituitary and pancreas, tissues that are known to be abundant in mRNA for the somatostatin subtype 2 receptor. BIM-23190 and BIM-23197 associated radioactivity in these tissues was prolonged compared with that of BIM-23014, especially in the SRIF-receptor-rich pituitary. BIM-23190 and BIM-23197 were more stable in vivoand much less subject to biliary excretion than BIM-23014. These properties account for the elevated plasma and target tissue concentrations of these new SRIF analogs. Based on higher plasma levels, greater distribution to target tissues and longer in vivo stability, BIM-23190 and BIM-23197 may prove to be superior to BIM-23014 for the treatment of acromegaly and some types of cancer.
Footnotes
-
Send reprint requests to: Thomas P. Davis, Ph.D., Department of Pharmacology, University of Arizona College of Medicine, 1609 N. Warren Ave., Tucson, AZ 85724. E-mail: davistp{at}u.arizona.edu
-
↵1 This work was supported by Grant RO1-DA11271-01 (T.P.D.) from the National Institutes of Health and by a contract from Biomeasure, Inc., Milford, MA.
- Abbreviations:
- Abu
- α-aminobutyric acid
- ACN
- acetonitrile
- GI
- gastrointestinal
- Nal
- β-(2-napthyl)alanine
- RCF
- relative centrifugal force
- SCLC
- small-cell lung cancer
- SRIF
- somatotropin release-inhibiting factor
- SSTR
- somatostatin receptor
- Received July 7, 1997.
- Accepted December 15, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
In this issue
Novel Somatostatin Analogs for the Treatment of Acromegaly and Cancer Exhibit Improved In Vivo Stability and Distribution
